Neuroimaging biomarkers of neurodegenerative diseases and dementia - Test2 - elhamkhani - TriplyDB

Neuroimaging biomarkers of neurodegenerative diseases and dementia

Neuroimaging biomarkers of neurodegenerative diseases and dementia

http://www.wikidata.org/entity/Q27691820

about

What can imaging tell us about cognitive impairment and dementia?Body fluid biomarkers in Alzheimer's disease HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.Diagnostic tools for alzheimer's disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews Magnetic resonance imaging findings in probable Creutzfeld-Jacob disease: comparison with electroencephalography and cerebrospinal fluid characteristics.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Neuropathologic correlates of regional brain volumes in a community cohort of older adults.Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?FDG-PET Contributions to the Pathophysiology of Memory Impairment.Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic?Brain MRI-markers Associate Differentially with Cognitive Versus Functional Decline Leading to Dementia.MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias.Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease.Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging.Fully automated structural MRI of the brain in clinical dementia workup.Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.[MRI in dementia-type diseases].Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.Advances in Neuro-Oncology Imaging Techniques

P2860

Q26749292-0BD2C094-3A55-45DB-A77D-C41EA26AF132 Q26830098-01AAD572-6AD8-4DD6-B20C-6FEBB6C95950 Q27015965-E5D1FFA3-EA68-40A4-BB76-9CC80DAECFA4 Q28081678-2BAFF2C8-984E-4C1B-87B5-A87451C1D120 Q30385567-51D367F0-185E-409D-9D9A-54134E340D41 Q34306619-2DD64B3A-0469-4F88-9F5E-CC7B42C5362F Q34742542-A04A5C98-FEA3-40DB-8026-9C6FC93B7B38 Q34776835-B23B985A-EEE4-4705-804D-9D61B5A483AE Q36037585-5813FC94-AADE-4598-9151-0940F78D332B Q38430889-08DFCCCA-3DDA-490B-B7AE-F89554EB22C1 Q38501853-732BCBA0-DF22-4E2C-BEA9-97DA87658CD6 Q38576278-0F40DBA8-B4FF-4911-99CB-74E4EBCCB8B9 Q38616797-3C798B55-BA47-4F8D-B316-10D103A03A79 Q38976917-5125E838-A8F9-4ECF-85AC-7861D266BFA8 Q39343679-5A0DEAA6-DBBF-49ED-B7E3-56D09EB82D7F Q40738433-D9C1D32A-0EF1-428B-81C6-527CA3B12E61 Q46013803-2D243415-38FE-40EB-9E7E-321DABB801FA Q47640111-F5291E90-0AF7-437C-8E8E-F33553943F47 Q48491951-4117EFD2-1EEF-4C33-A0C7-6BBE8710A276 Q50591685-8BB82164-7265-4D70-9E14-B5C931193616 Q53011251-3088C4D3-8F67-42C1-BA43-E72A28FEFBDB Q55069579-9D69DDF3-1DFB-4B67-8573-82F84C99C469 Q57060813-910F9FE3-E29F-4CE6-B090-DC954D0038A3

P2860

Neuroimaging biomarkers of neurodegenerative diseases and dementia

http://www.wikidata.org/entity/Q27691820

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@ast

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@en

Neuroimaging biomarkers of neurodegenerative diseases and dementia.

@nl

type

label

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@ast

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@en

Neuroimaging biomarkers of neurodegenerative diseases and dementia.

@nl

prefLabel

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@ast

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@en

Neuroimaging biomarkers of neurodegenerative diseases and dementia.

@nl

P1433

Q27691820-444703E3-A351-4B1A-A772-11B83434F716

P1476

Q27691820-1B3CC7D8-A2E7-4501-93DB-9241043562B0

P2860

Q27691820-001C8F6B-E293-4414-B202-64076606BA46

Q27691820-017F5CFB-E23E-46D8-B5ED-77B4B797237C

Q27691820-019310B6-CB27-47B5-AACA-88BD4546ABAC

Q27691820-02E4965A-82B1-44E7-974F-7A2BE5ED3068

Q27691820-03313B71-3058-4E41-8F1E-AF2250E6BAF7

Q27691820-033D0798-EE0D-4B00-B06D-E84DF0C77CA3

Q27691820-037FE09D-35E8-4D1A-823F-35868EE33F69

Q27691820-04271A8C-520C-4288-8A7D-818F74857AEC

Q27691820-056176E2-5730-47E9-BF72-AAA4562714B9

Q27691820-05F0DA94-93E2-47F8-89FD-B1025B2D8627

P304

Q27691820-0CEC6DC4-5161-4747-B016-62C2E53A0CA0

P31

Q27691820-7F8AF4D1-6DF9-4BE3-A7A5-7C84CB5E6889

P356

Q27691820-1E945A17-2E73-40AE-B8EF-8E823F099EF1

P407

Q27691820-CF755649-C78F-4B9D-9AA9-73C4FC926C1A

P433

Q27691820-F2EF731E-0E40-4F16-A3FE-BFB7360926F1

P478

Q27691820-8CD0719E-0D14-4E02-962E-B1C6528C91F3

P50

Q27691820-75F5FC69-7F4B-4791-BC76-B57F97CD0AE8

Q27691820-E0C07885-A109-48A8-BBFD-D140DF6DA0D0

P577

Q27691820-8F27457E-0C29-4599-8BE9-34CC5673D6A7

P698

Q27691820-FAF3E3E9-A4F2-421A-AFDA-EE39F20D0904

P921

Q27691820-3FEF8352-2D5E-4C54-A7B5-509A9DAE91D4

Q27691820-6ED08F1F-3241-46BA-A91E-E7F15C695E02

Q27691820-7B2ACC2D-0C8D-4291-A57E-71911BC937C8

Q27691820-B134A02B-BA71-4735-A880-7354E119D7D2

P932

Q27691820-D7675201-7DD9-408B-BE4B-582B6959CB3E

P356

P1433

Seminars in Neurology

P1476

Neuroimaging biomarkers of neurodegenerative diseases and dementia

@en

P2860

Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research

Magnetic Resonance Techniques in Multiple Sclerosis

Defining the clinical course of multiple sclerosis: Results of an international survey

Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

The neural basis of surface dyslexia in semantic dementia

Brain imaging in Alzheimer disease

P304

386-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0033-1359312

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J. Saykin

Shannon L. Risacher

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24234359

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

3975244

http://www.w3.org/2001/XMLSchema#string